French drug developers face HIV fallout.
D001709:Biotechnology; D004274:DNA, Recombinant; D004345:Drug Industry / Q000592:standards*; D005602:France; D015658:HIV Infections / Q000635:transmission*; D006801:Humans
D004274:DNA, Recombinant